Two years into its OTC drug quality-control remediation program, Johnson & Johnson has received an FDA warning letter concerning the firm’s handling of consumer complaints for consumer products regulated as devices.
The May 22 letter cites violations related to K-Y brand moisturizers, O.B. tampons and Reach dental floss and suggests that...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?